DRUGBright Minds Biosciences Inc.

Healthcare
$52.39-16% 1Y

The financials

Bright Minds Biosciences Inc. by the numbers

For the full year FY2025, revenue was CAD 1.5M (+4943% year on year) and net income −CAD 12M.

Bright Minds Biosciences Inc. income statement, Q4 2019 against the same quarter a year earlier
Income statementQ4 2019
Net income−CAD 79K
Diluted EPS−CAD 0.19

Biotechnology

Ranks #164 of 194 by RyuScore

Compare peers
SPRY-6.6%
ARS Pharmaceuticals, Inc.
ASMB-2.4%
Assembly Biosciences
TECX-4.4%
Tectonic Therapeutic, Inc.
EIKN-12%
Eikon Therapeutics, Inc.
AUTL-2.5%
Autolus Therapeutics plc
ALT-2.5%
Altimmune, Inc.